Skip to content
Use caution Drug recall · FDA · Published January 26, 2016

Amerisource Health Recalls Candesartan Cilexetil 16mg Tablets

Amerisource Health Services recalls 16 mg Candesartan Cilexetil tablets due to failed impurity specifications. Check lot #153855.

🇺🇸 FDA recall #D-0660-2016DrugAmerisource Health Services ›
Take action

Contact the company

Recalling firmAmerisource Health Services2550 John Glenn Ave, Suite A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

What happened, in plain English

Amerisource Health Services is recalling one lot of Candesartan Cilexetil Tablets, 16 mg, because the product failed impurity and degradation specifications during a 9-month stability test. The recall affects 716 cartons distributed nationwide. No specific remedy or return instructions are provided in this record. Read more at govinfonow.com/recall/43210-amerisource-health-recalls-candesartan-cilexetil-16mg-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/43210-amerisource-health-recalls-candesartan-cilexetil-16mg-tablets · Updated October 11, 2026 · FDA enforcement record: FDA #D-0660-2016

Cite this page

“Amerisource Health Recalls Candesartan Cilexetil 16mg Tablets.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43210-amerisource-health-recalls-candesartan-cilexetil-16mg-tablets. Based on FDA recall #D-0660-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0660-2016%22&limit=1).

Why it’s dangerous

The tablets failed to meet specifications for impurities and degradation after 9 months of stability testing. This means the chemical composition of the drug may have changed over time, potentially affecting its safety or effectiveness, although specific health outcomes are not detailed in the record.

Who’s affected

Patients currently taking Candesartan Cilexetil 16 mg prescribed by a doctor, specifically those who may have received the recalled lot from pharmacies across the United States. Individuals with high blood pressure or heart failure are the primary users of this medication.

How to tell if you have this one

Check your medication bottle for NDC 68084-877-25 (carton) or NDC 68084-877-95 (individual dose). Verify that the Lot number is 153855 and the expiration date is 01/2017. The product was distributed by American Health Packaging in Columbus, Ohio.

  • Brand
    Amerisource Health Services
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Call the pharmacy where you filled your prescription to confirm if your specific bottle matches the recalled lot number and NDC codes.

  2. Consult Your Doctor

    Speak with your healthcare provider before stopping or changing your medication dosage to ensure your treatment plan remains safe.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Jan 26, 201612. FDA classified it Class III: Feb 11, 201623. Published in FDA’s Enforcement Report: Feb 17, 201634. FDA terminated the recall: Jan 11, 2017420162017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0660-2016 (January 26, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0660-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA